Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Nathalie, Rabbe"'
Autor:
Michaël Duruisseaux, Nathalie Rabbe, Martine Antoine, Thibault Vieira, Virginie Poulot, Jacques Cadranel, Marie Wislez
Publikováno v:
ERJ Open Research, Vol 3, Iss 1 (2017)
Invasive mucinous adenocarcinoma (IMA) is a mucinous variant of lepidic predominant lung adenocarcinoma (LPA) and associated with a worse prognosis. We postulated that cytokine expression would enable us to differentiate IMA from LPA in terms of prog
Externí odkaz:
https://doaj.org/article/4602e74b793c4ff888e713c7cec9c866
Autor:
Pierre Laurent-Puig, H. Janicot, Charles Ricordel, Hélène Blons, Alexandra Langlais, Laurent Greillier, Philippe Fraisse, Marie Wislez, Isabelle Monnet, Nathalie Rabbe, Alain Makinson, Clarisse Audigier-Valette, Jean Philippe Spano, Elodie Amour, Julien Mazieres, Charlotte Domblides, Jacques Cadranel, Xavier Quantin, Armelle Lavolé, Lize Kiakouama-Maleka
Publikováno v:
Lung Cancer
Lung Cancer, 2021, 157, pp.124-130. ⟨10.1016/j.lungcan.2021.05.013⟩
Lung Cancer, 2021, 157, pp.124-130. ⟨10.1016/j.lungcan.2021.05.013⟩
International audience; IntroductionHIV is an exclusion criterion for most lung cancer (LC) trials, however LC is the most common non-AIDS-defined malignancy in people living with HIV (PLHIV), poorer prognosis than the general population. Circulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::388ec124d0e3a9e85331be7209356ea0
https://inria.hal.science/hal-03526372
https://inria.hal.science/hal-03526372
Autor:
Issam Arrouss, Fariba Nemati, Fernando Roncal, Marie Wislez, Karim Dorgham, David Vallerand, Nathalie Rabbe, Narjesse Karboul, Françoise Carlotti, Jeronimo Bravo, Dominique Mazier, Didier Decaudin, Angelita Rebollo
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60816 (2013)
PURPOSE: PP2A is a serine/threonine phosphatase critical to physiological processes, including apoptosis. Cell penetrating peptides are molecules that can translocate into cells without causing membrane damage. Our goal was to develop cell-penetratin
Externí odkaz:
https://doaj.org/article/9f541d1e4a454971b8d5263704e9489c
Autor:
Marie Wislez, Jacques Cadranel, Nathalie Rabbe, Armelle Lavolé, Anne-Marie Ruppert, Martine Antoine, Xavier Mignard, G. Pontdeme, Roger Lacave
Publikováno v:
Revue des Maladies Respiratoires Actualités. 9:202-212
Resume Ces dernieres annees ont vu la decouverte dans les CBNPC d’alterations moleculaires agissant comme « drivers » oncogeniques et conferant une sensibilite a des traitements cibles, definissant ainsi l’addiction oncogenique. Ces progres con
Autor:
Simon Baldacci, Olivier Molinier, Etienne Giroux-Leprieur, Valérie Gounant, Anne-Marie Ruppert, M. Wislez, Gilles Robinet, Charles Ricordel, Anne-Claire Toffart, Eric Pichon, Bertrand Mennecier, Dorine Templement-Grangerat, Clarisse Audigier-Valette, Julien Mazieres, Charlotte Domblides, Ludovic Doucet, Florian Guisier, Karen Leroy, Nathalie Rabbe, Fabrice Barlesi, Martine Antoine, Maurice Pérol, Isabelle Monnet
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 15(5)
Introduction Immune checkpoint inhibitors (ICIs) have improved cancer prognosis but have not been evaluated specifically in sarcomatoid carcinoma (SC), a rare lung cancer subtype with poor prognosis. As such, our study sought to retrospectively asses
Autor:
Marie Christine Copin, Philippe Jamme, Radj Gervais, Valérie Grégoire, Nathalie Rabbe, Nicolas Richard, Simon Baldacci, Alexis B. Cortot, Fabienne Escande, Maeva Kyheng, Marie Wislez, Eric Dansin, Zoulika Kherrouche, C. Descarpentries
Publikováno v:
Clinical Lung Cancer
Clinical Lung Cancer, Elsevier, 2019, 20 (4), pp.297-304.e1. ⟨10.1016/j.cllc.2019.02.013⟩
Clinical Lung Cancer, 2019, 20 (4), pp.297-304.e1. ⟨10.1016/j.cllc.2019.02.013⟩
Clinical Lung Cancer, Elsevier, 2019, 20 (4), pp.297-304.e1. ⟨10.1016/j.cllc.2019.02.013⟩
Clinical Lung Cancer, 2019, 20 (4), pp.297-304.e1. ⟨10.1016/j.cllc.2019.02.013⟩
Background Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) have shown efficacy in the treatment of ALK-rearranged non–small-cell lung cancer (NSCLC), but the disease eventually progresses in all patients. In many cases, resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8131ac1211fcec2c008eebd3d7e8788
https://hal-normandie-univ.archives-ouvertes.fr/hal-02267645
https://hal-normandie-univ.archives-ouvertes.fr/hal-02267645
Autor:
Marie Wislez, Nathalie Rabbe, Joëlle Perez, Martine Antoine, T. Vieira, Jacques Cadranel, Anne-Marie Ruppert, Laurent Baud, Michael Duruisseaux
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (3), pp.179-188. ⟨10.1016/j.bulcan.2018.11.014⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (3), pp.179-188. ⟨10.1016/j.bulcan.2018.11.014⟩
International audience; Calpain 1 is a proinflammatory calcium-activated cysteine protease, which can be partly externalized. Extracellular calpains limit inflammatory processes and promote tissue repair, through cell proliferation and migration. Tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4244706671532d43415032773b63971f
https://hal.sorbonne-universite.fr/hal-02339860
https://hal.sorbonne-universite.fr/hal-02339860
Autor:
Nicolas Girard, Alexis B. Cortot, Denis Moro-Sibilot, Antoinette Lemoine, Raphaël Saffroy, Sylvie Lantuejoul, Xavier Mignard, Isabelle Rouquette, Nathalie Rabbe, Anne-Marie Ruppert, Julie Vasseur, Marie Wislez, Julien Mazieres, Jacques Cadranel, Vincent Fallet, Françoise Thivolet-Béjui, Martine Antoine
Publikováno v:
Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2018, 13 (12), pp.1962-1967. ⟨10.1016/j.jtho.2018.08.008⟩
Journal of Thoracic Oncology, 2018, 13 (12), pp.1962-1967. ⟨10.1016/j.jtho.2018.08.008⟩
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2018, 13 (12), pp.1962-1967. ⟨10.1016/j.jtho.2018.08.008⟩
Journal of Thoracic Oncology, 2018, 13 (12), pp.1962-1967. ⟨10.1016/j.jtho.2018.08.008⟩
Introduction MNNG HOS transforming gene (MET) abnormalities such as amplification and exon 14 mutations may be responsive to targeted therapies. They are prevalent in lung sarcomatoid carcinomas (LSCs) and must be diagnosed as efficiently as possible
Autor:
L. Doucet, Valérie Gounant, C. Domblides, Anne-Claire Toffart, Etienne Giroux-Leprieur, Martine Antoine, Florian Guisier, Clarisse Audigier-Valette, Olivier Molinier, Julien Mazieres, Fabrice Barlesi, Maurice Pérol, Marie Wislez, D. Templement-Grangerat, A.-M. Ruppert, Simon Baldacci, E. Pichon, Charles Ricordel, Nathalie Rabbe, Bertrand Mennecier, Gilles Robinet, Isabelle Monnet
Publikováno v:
Revue des Maladies Respiratoires. 36:A19-A20
Introduction Les inhibiteurs de checkpoint immunitaire (ICI) ont permis une nette amelioration du pronostic dans le cancer bronchique non a petites cellules (CBNPC). Des donnees prealables ont montre que l’expression de PD-L1 et l’infiltrat immun
Autor:
T. Vieira, Armelle Lavolé, Anita Rodenas, Nathalie Rabbe, Marie Wislez, Cécile Hamard, Perrine Créquit, Charlotte Domblides, Martine Antoine, Jacques Cadranel
Publikováno v:
AIDS (London, England). 32(4)
OBJECTIVE Immunotherapies targeting the programmed cell death-1 (PD-1)/PD-ligand 1 (PD-L1) checkpoint improved prognosis in lung cancer. PD-1/PD-L1 status, however, has not been investigated in human immunodeficiency virus (HIV)-positive patients. Th